Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes

The suitability of triacetyloleandomycin (TAO) metabolite complex formation and metyrapone binding to reduced cytochrome P450 as a means for selective isozyme quantitation has been studied. Although isozymes of both subfamilies bind metyrapone in the reduced state, selective quantitation of 2B isozy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical pharmacology 1993-06, Vol.45 (11), p.2239-2250
Hauptverfasser: Roos, Peter H., Golub-Ciosk, Beata, Kallweit, Petra, Kauczinski, Detlef, Hanstein, Walter G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2250
container_issue 11
container_start_page 2239
container_title Biochemical pharmacology
container_volume 45
creator Roos, Peter H.
Golub-Ciosk, Beata
Kallweit, Petra
Kauczinski, Detlef
Hanstein, Walter G.
description The suitability of triacetyloleandomycin (TAO) metabolite complex formation and metyrapone binding to reduced cytochrome P450 as a means for selective isozyme quantitation has been studied. Although isozymes of both subfamilies bind metyrapone in the reduced state, selective quantitation of 2B isozymes through the metyrapone complex is possible after complex formation of P450 3A with a TAO metabolite. Thus, consecutive application of both reactions allows the spectroscopic quantitation of P450 3A and 2B isozymes. Complete conversion of P450 3A into the complex, a precondition for P450 3A quantitation, requires NADH in addition to NADPH. A precise collective quantitation of 3A + 2B isozymes as metyrapone complexes alone is not possible because the corresponding complexes possess different molar extinction coefficients, i.e 71.5 and 52 mM −1 cm −1 at 446–490 nm, respectively. The formation of the TAO complex appears to be quite specific, since it correlates well with 3A-specific enzymatic activities, i.e. TAO N-demethylation and formation of 2β-hydroxy-, 15β-hydroxy- and 6-dehydrotestosterone. P450 3A levels in liver microsomes of male rats either untreated or treated with TAO, dexamethasone (DEX), phenobarbital or hexachlorobenzene amount to 13%, 78%, 66%, 24% and 11% of total P450, respectively. Good correlation between these values and P450 3A-specific enzymatic activities is obtained. By the spectroscopic method, P450 2B isozymes could not be detected in microsomes of untreated rats. With TAO, DEX and hexachlorobenzene the microsomal 2B level is elevated to about 20% of total P450, i.e. to 0.8, 0.4 and 0.4 nmol P450/mg protein, respectively. 2B levels of about 60% of total P450 (0.75 nmol P450/mg protein) are obtained by phenobarbital treatment. Immunoblotting with anti-P450 2B shows that the ratio of expressed 2B1 and 2B2 differs depending on the type of inducer. DEX predominantly leads to induction of 2B2, which may explain the low pentoxyresorufin O-depentylase activity in these microsomes.
doi_str_mv 10.1016/0006-2952(93)90195-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75803445</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006295293901953</els_id><sourcerecordid>75803445</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-ce51b1d0c5d3b72f21c7070f9bd0f39dd49e50eee4a5726eb8dc2d13b03071803</originalsourceid><addsrcrecordid>eNp9kEFr2zAYhsVoydJs_2ADHcpoD94ky7KlS2GEpi0E1sN2FrL0edOwrVRSQtNfX7kJORYkhPQ-34t4EPpCyXdKaP2DEFIXpeTllWTXklDJC_YBzaloWH6uxRman5CP6CLG_9NV1HSGZoLTRtTVHI0rHwadnB-x73Dv_urR4mkPkHTre5cAGz9seniGiHVeOdFjxJ0POEIPJrkd4KetHpNLpyKzT978C34A_Fhxgl30L_sB4id03uk-wufjuUB_Vre_l_fF-tfdw_LnujBM1KkwwGlLLTHcsrYpu5KahjSkk60lHZPWVhI4AYBK86asoRXWlJayljDSUEHYAn079G6Cf9pCTGpw0UDf6xH8NqqGZ6iqeAarA2iCjzFApzbBDTrsFSVq0qwmaWpyqCRTb5oVy2Nfj_3bdgB7Gjp6zfnlMdfR6L4LejQunrBKSMY4zdjNAYPsYucgqGgcjAasC9msst69_49X7YeaCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75803445</pqid></control><display><type>article</type><title>Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Roos, Peter H. ; Golub-Ciosk, Beata ; Kallweit, Petra ; Kauczinski, Detlef ; Hanstein, Walter G.</creator><creatorcontrib>Roos, Peter H. ; Golub-Ciosk, Beata ; Kallweit, Petra ; Kauczinski, Detlef ; Hanstein, Walter G.</creatorcontrib><description>The suitability of triacetyloleandomycin (TAO) metabolite complex formation and metyrapone binding to reduced cytochrome P450 as a means for selective isozyme quantitation has been studied. Although isozymes of both subfamilies bind metyrapone in the reduced state, selective quantitation of 2B isozymes through the metyrapone complex is possible after complex formation of P450 3A with a TAO metabolite. Thus, consecutive application of both reactions allows the spectroscopic quantitation of P450 3A and 2B isozymes. Complete conversion of P450 3A into the complex, a precondition for P450 3A quantitation, requires NADH in addition to NADPH. A precise collective quantitation of 3A + 2B isozymes as metyrapone complexes alone is not possible because the corresponding complexes possess different molar extinction coefficients, i.e 71.5 and 52 mM −1 cm −1 at 446–490 nm, respectively. The formation of the TAO complex appears to be quite specific, since it correlates well with 3A-specific enzymatic activities, i.e. TAO N-demethylation and formation of 2β-hydroxy-, 15β-hydroxy- and 6-dehydrotestosterone. P450 3A levels in liver microsomes of male rats either untreated or treated with TAO, dexamethasone (DEX), phenobarbital or hexachlorobenzene amount to 13%, 78%, 66%, 24% and 11% of total P450, respectively. Good correlation between these values and P450 3A-specific enzymatic activities is obtained. By the spectroscopic method, P450 2B isozymes could not be detected in microsomes of untreated rats. With TAO, DEX and hexachlorobenzene the microsomal 2B level is elevated to about 20% of total P450, i.e. to 0.8, 0.4 and 0.4 nmol P450/mg protein, respectively. 2B levels of about 60% of total P450 (0.75 nmol P450/mg protein) are obtained by phenobarbital treatment. Immunoblotting with anti-P450 2B shows that the ratio of expressed 2B1 and 2B2 differs depending on the type of inducer. DEX predominantly leads to induction of 2B2, which may explain the low pentoxyresorufin O-depentylase activity in these microsomes.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/0006-2952(93)90195-3</identifier><identifier>PMID: 8517864</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Analytical, structural and metabolic biochemistry ; Animals ; Antibodies - immunology ; Biological and medical sciences ; Cytochrome P-450 Enzyme System - analysis ; Cytochrome P-450 Enzyme System - immunology ; Cytochrome P-450 Enzyme System - metabolism ; Dexamethasone ; Enzymes and enzyme inhibitors ; Female ; Fundamental and applied biological sciences. Psychology ; Isoenzymes - analysis ; Isoenzymes - metabolism ; Male ; Metyrapone - metabolism ; Microsomes, Liver - enzymology ; Oxidoreductases ; Phenobarbital ; Rats ; Rats, Sprague-Dawley ; Spectrophotometry - methods ; Troleandomycin - metabolism</subject><ispartof>Biochemical pharmacology, 1993-06, Vol.45 (11), p.2239-2250</ispartof><rights>1993</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-ce51b1d0c5d3b72f21c7070f9bd0f39dd49e50eee4a5726eb8dc2d13b03071803</citedby><cites>FETCH-LOGICAL-c386t-ce51b1d0c5d3b72f21c7070f9bd0f39dd49e50eee4a5726eb8dc2d13b03071803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0006-2952(93)90195-3$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4893351$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8517864$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roos, Peter H.</creatorcontrib><creatorcontrib>Golub-Ciosk, Beata</creatorcontrib><creatorcontrib>Kallweit, Petra</creatorcontrib><creatorcontrib>Kauczinski, Detlef</creatorcontrib><creatorcontrib>Hanstein, Walter G.</creatorcontrib><title>Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes</title><title>Biochemical pharmacology</title><addtitle>Biochem Pharmacol</addtitle><description>The suitability of triacetyloleandomycin (TAO) metabolite complex formation and metyrapone binding to reduced cytochrome P450 as a means for selective isozyme quantitation has been studied. Although isozymes of both subfamilies bind metyrapone in the reduced state, selective quantitation of 2B isozymes through the metyrapone complex is possible after complex formation of P450 3A with a TAO metabolite. Thus, consecutive application of both reactions allows the spectroscopic quantitation of P450 3A and 2B isozymes. Complete conversion of P450 3A into the complex, a precondition for P450 3A quantitation, requires NADH in addition to NADPH. A precise collective quantitation of 3A + 2B isozymes as metyrapone complexes alone is not possible because the corresponding complexes possess different molar extinction coefficients, i.e 71.5 and 52 mM −1 cm −1 at 446–490 nm, respectively. The formation of the TAO complex appears to be quite specific, since it correlates well with 3A-specific enzymatic activities, i.e. TAO N-demethylation and formation of 2β-hydroxy-, 15β-hydroxy- and 6-dehydrotestosterone. P450 3A levels in liver microsomes of male rats either untreated or treated with TAO, dexamethasone (DEX), phenobarbital or hexachlorobenzene amount to 13%, 78%, 66%, 24% and 11% of total P450, respectively. Good correlation between these values and P450 3A-specific enzymatic activities is obtained. By the spectroscopic method, P450 2B isozymes could not be detected in microsomes of untreated rats. With TAO, DEX and hexachlorobenzene the microsomal 2B level is elevated to about 20% of total P450, i.e. to 0.8, 0.4 and 0.4 nmol P450/mg protein, respectively. 2B levels of about 60% of total P450 (0.75 nmol P450/mg protein) are obtained by phenobarbital treatment. Immunoblotting with anti-P450 2B shows that the ratio of expressed 2B1 and 2B2 differs depending on the type of inducer. DEX predominantly leads to induction of 2B2, which may explain the low pentoxyresorufin O-depentylase activity in these microsomes.</description><subject>Analytical, structural and metabolic biochemistry</subject><subject>Animals</subject><subject>Antibodies - immunology</subject><subject>Biological and medical sciences</subject><subject>Cytochrome P-450 Enzyme System - analysis</subject><subject>Cytochrome P-450 Enzyme System - immunology</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Dexamethasone</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Isoenzymes - analysis</subject><subject>Isoenzymes - metabolism</subject><subject>Male</subject><subject>Metyrapone - metabolism</subject><subject>Microsomes, Liver - enzymology</subject><subject>Oxidoreductases</subject><subject>Phenobarbital</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Spectrophotometry - methods</subject><subject>Troleandomycin - metabolism</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFr2zAYhsVoydJs_2ADHcpoD94ky7KlS2GEpi0E1sN2FrL0edOwrVRSQtNfX7kJORYkhPQ-34t4EPpCyXdKaP2DEFIXpeTllWTXklDJC_YBzaloWH6uxRman5CP6CLG_9NV1HSGZoLTRtTVHI0rHwadnB-x73Dv_urR4mkPkHTre5cAGz9seniGiHVeOdFjxJ0POEIPJrkd4KetHpNLpyKzT978C34A_Fhxgl30L_sB4id03uk-wufjuUB_Vre_l_fF-tfdw_LnujBM1KkwwGlLLTHcsrYpu5KahjSkk60lHZPWVhI4AYBK86asoRXWlJayljDSUEHYAn079G6Cf9pCTGpw0UDf6xH8NqqGZ6iqeAarA2iCjzFApzbBDTrsFSVq0qwmaWpyqCRTb5oVy2Nfj_3bdgB7Gjp6zfnlMdfR6L4LejQunrBKSMY4zdjNAYPsYucgqGgcjAasC9msst69_49X7YeaCQ</recordid><startdate>19930609</startdate><enddate>19930609</enddate><creator>Roos, Peter H.</creator><creator>Golub-Ciosk, Beata</creator><creator>Kallweit, Petra</creator><creator>Kauczinski, Detlef</creator><creator>Hanstein, Walter G.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930609</creationdate><title>Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes</title><author>Roos, Peter H. ; Golub-Ciosk, Beata ; Kallweit, Petra ; Kauczinski, Detlef ; Hanstein, Walter G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-ce51b1d0c5d3b72f21c7070f9bd0f39dd49e50eee4a5726eb8dc2d13b03071803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Analytical, structural and metabolic biochemistry</topic><topic>Animals</topic><topic>Antibodies - immunology</topic><topic>Biological and medical sciences</topic><topic>Cytochrome P-450 Enzyme System - analysis</topic><topic>Cytochrome P-450 Enzyme System - immunology</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Dexamethasone</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Isoenzymes - analysis</topic><topic>Isoenzymes - metabolism</topic><topic>Male</topic><topic>Metyrapone - metabolism</topic><topic>Microsomes, Liver - enzymology</topic><topic>Oxidoreductases</topic><topic>Phenobarbital</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Spectrophotometry - methods</topic><topic>Troleandomycin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roos, Peter H.</creatorcontrib><creatorcontrib>Golub-Ciosk, Beata</creatorcontrib><creatorcontrib>Kallweit, Petra</creatorcontrib><creatorcontrib>Kauczinski, Detlef</creatorcontrib><creatorcontrib>Hanstein, Walter G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roos, Peter H.</au><au>Golub-Ciosk, Beata</au><au>Kallweit, Petra</au><au>Kauczinski, Detlef</au><au>Hanstein, Walter G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes</atitle><jtitle>Biochemical pharmacology</jtitle><addtitle>Biochem Pharmacol</addtitle><date>1993-06-09</date><risdate>1993</risdate><volume>45</volume><issue>11</issue><spage>2239</spage><epage>2250</epage><pages>2239-2250</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>The suitability of triacetyloleandomycin (TAO) metabolite complex formation and metyrapone binding to reduced cytochrome P450 as a means for selective isozyme quantitation has been studied. Although isozymes of both subfamilies bind metyrapone in the reduced state, selective quantitation of 2B isozymes through the metyrapone complex is possible after complex formation of P450 3A with a TAO metabolite. Thus, consecutive application of both reactions allows the spectroscopic quantitation of P450 3A and 2B isozymes. Complete conversion of P450 3A into the complex, a precondition for P450 3A quantitation, requires NADH in addition to NADPH. A precise collective quantitation of 3A + 2B isozymes as metyrapone complexes alone is not possible because the corresponding complexes possess different molar extinction coefficients, i.e 71.5 and 52 mM −1 cm −1 at 446–490 nm, respectively. The formation of the TAO complex appears to be quite specific, since it correlates well with 3A-specific enzymatic activities, i.e. TAO N-demethylation and formation of 2β-hydroxy-, 15β-hydroxy- and 6-dehydrotestosterone. P450 3A levels in liver microsomes of male rats either untreated or treated with TAO, dexamethasone (DEX), phenobarbital or hexachlorobenzene amount to 13%, 78%, 66%, 24% and 11% of total P450, respectively. Good correlation between these values and P450 3A-specific enzymatic activities is obtained. By the spectroscopic method, P450 2B isozymes could not be detected in microsomes of untreated rats. With TAO, DEX and hexachlorobenzene the microsomal 2B level is elevated to about 20% of total P450, i.e. to 0.8, 0.4 and 0.4 nmol P450/mg protein, respectively. 2B levels of about 60% of total P450 (0.75 nmol P450/mg protein) are obtained by phenobarbital treatment. Immunoblotting with anti-P450 2B shows that the ratio of expressed 2B1 and 2B2 differs depending on the type of inducer. DEX predominantly leads to induction of 2B2, which may explain the low pentoxyresorufin O-depentylase activity in these microsomes.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8517864</pmid><doi>10.1016/0006-2952(93)90195-3</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2952
ispartof Biochemical pharmacology, 1993-06, Vol.45 (11), p.2239-2250
issn 0006-2952
1873-2968
language eng
recordid cdi_proquest_miscellaneous_75803445
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Analytical, structural and metabolic biochemistry
Animals
Antibodies - immunology
Biological and medical sciences
Cytochrome P-450 Enzyme System - analysis
Cytochrome P-450 Enzyme System - immunology
Cytochrome P-450 Enzyme System - metabolism
Dexamethasone
Enzymes and enzyme inhibitors
Female
Fundamental and applied biological sciences. Psychology
Isoenzymes - analysis
Isoenzymes - metabolism
Male
Metyrapone - metabolism
Microsomes, Liver - enzymology
Oxidoreductases
Phenobarbital
Rats
Rats, Sprague-Dawley
Spectrophotometry - methods
Troleandomycin - metabolism
title Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T12%3A17%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formation%20of%20ligand%20and%20metabolite%20complexes%20as%20a%20means%20for%20selective%20quantitation%20of%20cytochrome%20P450%20isozymes&rft.jtitle=Biochemical%20pharmacology&rft.au=Roos,%20Peter%20H.&rft.date=1993-06-09&rft.volume=45&rft.issue=11&rft.spage=2239&rft.epage=2250&rft.pages=2239-2250&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/0006-2952(93)90195-3&rft_dat=%3Cproquest_cross%3E75803445%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75803445&rft_id=info:pmid/8517864&rft_els_id=0006295293901953&rfr_iscdi=true